Items Tagged ‘colorectal cancer’

November 5, 2018

Pharmacogenomics: finding the right drug, dose for cancer therapy

By Sharon Rosen sharonhrosen

Each year, nearly 300,000 patients receive the lifesaving chemotherapy 5-fluorouracil (5-FU) to treat many types of cancer, including colorectal, breast, bowel, skin, pancreatic, and esophageal cancer. While it can be an effective treatment, it doesn’t work for everyone. In fact, up to 30 percent of those who receive the standard dose can have serious, life-threatening […]

View full entry

Tags: #5-fluorouracil, #5-FU chemotherapy, #chemotherapy side effects, #DPYD gene, #drug-gene interactions, #gene verifier model, breast cancer, chemotherapy, colorectal cancer, mayo clinic, Mayo Clinic Cancer Center, Mayo Clinic Center for Individualized Medicine


June 21, 2018

Taking action: using pharmacogenomics testing to individualize care for colorectal cancer

By Sharon Rosen sharonhrosen

Every day, Pashtoon Kasi, M.D., M.B.B.S. is inspired by his patients with colorectal cancer to deliver the best, individualized care to meet their unique needs. As an oncologist at Mayo Clinic’s campus in Florida, Dr. Kasi is seeing many of the growing number of younger patients – those in their 20’s, 30’s and 40’s – diagnosed with […]

View full entry

Tags: #CIMCon18, #clinical research, #drug-gene interactions, #Individualizing Medicine 2018, #medication side effects, #pharmacogenomics testing, #pre-emptive pharmacogenomics testing, center for individualized medicine, chemotherapy, colorectal cancer, Genetic Testing, mayo clinic


October 3, 2017

Liquid biopsies: detecting and treating cancer sooner

By Sharon Rosen sharonhrosen

What if a blood test could discover cancer before a tumor first appears or before the first signs of cancer recurrence are seen by a radiology study? In fact, these types of blood tests, often called liquid biopsies, are already changing clinical care for patients with cancer. Researchers and physicians in Mayo Clinic Center for […]

View full entry

Tags: #blood tests, #cancer treatment, #cell-free DNA testing, #CIMCon17, #circulating tumor cells, #Dr. Minetta Liu, #Individualizing Medicine 2017, #liquid biopsies, Advanced Cancer, breast cancer, cancer, cancer screening


March 23, 2017

Genetics and biology hold the keys to better screening, treatment of colon cancer

By Sharon Rosen sharonhrosen

Colon cancer is the fourth most common form of cancer diagnosis in America. However, it is very treatable when caught in early stages. Throughout the month of March, Mayo Clinic is enlisting the help of a giant inflatable colon to help patients learn firsthand how colon cancer develops and the key role that screening plays […]

View full entry

Tags: #Colon cancer screening, #colon cancer treatment, #Colon display, #Dr. Thorvardur Halfdanarson, #inherited colon cancer, #Katie Agre, #Mayo Clinic Cancer Education Program, center for individualized medicine, colon cancer, colorectal cancer, Dr. Nicholas Chia, Genetic Counselor


March 7, 2017

March 16: Strollin’ Colon – Colon Cancer Awareness Event

By Sharon Rosen sharonhrosen

Do you know the facts about colon cancer – what types of screening tests are available to prevent or detect it early, whether you’re at risk, and if so, how it is treated? You can learn more by taking a walk through the inflatable Strollin’ Colon, which will be at all Mayo Clinic campuses through […]

View full entry

Tags: #Center for Individualzied Medicine, #ColorectalCancer, #Dr. Thorvardur Halfdanarson, #Hereditary colorectal cancer, #Katherine Agre, #Microbiome research, #Strollin' Colon, colon cancer, colorectal cancer, Dr. Nicholas Chia, Genetic Counselor, Genetic Testing


July 5, 2016

Looking for Clues About How Colorectal Cancer Develops

By Sharon Rosen sharonhrosen

Our bodies are home to around 100 trillion microbes, mostly bacteria, inside and out. Within the human body, microbial genes outnumber human genes 100 to 1. This is the microbiome — and we couldn’t live without it. There are diverse, complex communities of microbes in the intestines, in the mouth, on the skin and elsewhere, living […]

View full entry

Tags: colorectal cancer, Dr. Nicholas Chia, Dr. Vanessa Hale, Gut Microbiome, Mayo Clinic Center for Individualized Medicine, microbiome, whole genomic sequencing


March 29, 2016

Mayo Clinic Expert Shares Five Things to Know About Colorectal Cancer

By Jeff Briggs JeffreyBriggs

March is Colon and Rectal Cancer Awareness Month Roughly 140,000 people are diagnosed with colorectal cancer in the U.S. each year. It is the third most common cancer and No. 2 cause of cancer-related deaths among men and women. Heidi Nelson, M.D., chief of surgery at Mayo Clinic, and director of the Mayo Clinic Center […]

View full entry

Tags: Biobank, center for individualized medicine, ColoGuard, colon cancer, colorectal, colorectal cancer, Dr. Heidi Nelson, Precision Medicine, rectal cancer


Mayo Clinic First to Offer Stool-Based DNA Screening Test for Colorectal Cancer

September 2, 2014

Mayo Clinic First to Offer Stool-Based DNA Screening Test for Colorectal Cancer

By Center for Individualized Medicine samuelsmith5209

Exact Sciences Corp. recently announced that Mayo Clinic will be the first health system to offer Cologuard®, the first and only Food and Drug Administration (FDA) approved, noninvasive stool DNA screening test for colorectal cancer. Cologuard will be available to patients through their primary care physicians at Mayo Clinic. Available by prescription only, Cologuard offers […]

View full entry

Tags: biomarker, biomarkers, cancer, center for individualized medicine, ColoGuard, colon cancer, colorectal, colorectal cancer, David Ahlquist, DNA, DNA Sequencing, dna test


October 3, 2013

#CIMCon2013 Rundown

By AJ Montpetit ajmontpetit

  “Individualized Medicine is no longer the stuff of science fiction.” —Richard Weinshilboum, M.D., Pharmacogenomic Program director and conference co-director This quote from pioneering , Richard Weinshilboum, M.D., set the tone for Individualizing Medicine 2013: From Promise to Practice. With more than 750 physicians, researchers, scientists, medical staff, genetic counselors and others gathering in Rochester to exchange ideas, it’s […]

View full entry

Tags: Bioethics, breast cancer, c. difficile, cancer, center for individualized medicine, colon cancer, colorectal cancer, DNA, exome, fecal transplant, gene sequencing, genetic


September 5, 2013

Molecular Biomarkers to Inform Adjuvant Therapy for Lynch Syndrome

By AJ Montpetit ajmontpetit

The most common hereditary colon cancer disorder, Lynch syndrome, increases the risk of colorectal cancer (CRC) and are usually caused by germline mutations in 1 of 4 mismatch repair (MMR) genes: MLH1, MSH2, MSH6 and PMS2. Identifying people who are at risk is important for their care, as well as the care of members of […]

View full entry

Tags: biomarker, biomarkers, cancer, colorectal cancer, Genetics, genome, genomics, individualized medicine, lynch syndrome, molecular biomarkers


Contact Us · Privacy Policy